Genetic defects in β-spectrin and tau sensitize C. elegans axons to movement-induced damage via torque-tension coupling

  1. Michael Krieg
  2. Jan Stühmer
  3. Juan G Cueva
  4. Richard Fetter
  5. Kerri A Spliker
  6. Daniel Cremers
  7. Kang Shen
  8. Alexander R Dunn
  9. Miriam B Goodman  Is a corresponding author
  1. Institute of Photonic Sciences, Spain
  2. Technical University of Munich, Germany
  3. Stanford University, United States

Abstract

Our bodies are in constant motion and so are the neurons that invade each tissue. Motion-induced neuron deformation and damage are associated with several neurodegenerative conditions. Here, we investigated the question of how the neuronal cytoskeleton protects axons and dendrites from mechanical stress, exploiting mutations in UNC-70 β-spectrin, PTL-1 tau/MAP2-like and MEC-7 β-tubulin proteins in Caenorhabditis elegans. We found that mechanical stress induces supercoils and plectonemes in the sensory axons of spectrin and tau double mutants. Biophysical measurements, super-resolution and electron microscopy, as well as numerical simulations of neurons as discrete, elastic rods provide evidence that a balance of torque, tension, and elasticity stabilizes neurons against mechanical deformation. We conclude that the spectrin and microtubule cytoskeletons work in combination to protect axons and dendrites from mechanical stress, and propose that defects in -spectrin and tau may sensitize neurons to damage.

Article and author information

Author details

  1. Michael Krieg

    Institute of Photonic Sciences, Barcelona, Spain
    Competing interests
    No competing interests declared.
  2. Jan Stühmer

    Department of Informatics, Technical University of Munich, München, Germany
    Competing interests
    No competing interests declared.
  3. Juan G Cueva

    Department of Molecular and Cellular Physiology, Stanford University, Stanford, United States
    Competing interests
    No competing interests declared.
  4. Richard Fetter

    Department of Molecular and Cellular Physiology, Stanford University, Stanford, United States
    Competing interests
    No competing interests declared.
  5. Kerri A Spliker

    Institute of Photonic Sciences, Barcelona, Spain
    Competing interests
    No competing interests declared.
  6. Daniel Cremers

    Department of Informatics, Technical University of Munich, München, Germany
    Competing interests
    No competing interests declared.
  7. Kang Shen

    Department of Biology, Stanford University, Stanford, United States
    Competing interests
    Kang Shen, Reviewing editor, eLife.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-4059-8249
  8. Alexander R Dunn

    Department of Chemical Engineering, Stanford University, Stanford, United States
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-6096-4600
  9. Miriam B Goodman

    Department of Molecular and Cellular Physiology, Stanford University, Stanford, United States
    For correspondence
    mbgoodmn@stanford.edu
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-5810-1272

Funding

National Institute of Neurological Disorders and Stroke (R01NS092099-02)

  • Alexander R Dunn
  • Miriam B Goodman

National Institute of Neurological Disorders and Stroke (5K99NS089942-02)

  • Michael Krieg

Howard Hughes Medical Institute

  • Kang Shen
  • Alexander R Dunn

H2020 European Research Council (ERC-2014-CoG)

  • Jan Stühmer
  • Daniel Cremers

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Anna Akhmanova, Utrecht University, Netherlands

Version history

  1. Received: July 29, 2016
  2. Accepted: January 17, 2017
  3. Accepted Manuscript published: January 18, 2017 (version 1)
  4. Version of Record published: February 8, 2017 (version 2)
  5. Version of Record updated: February 10, 2017 (version 3)

Copyright

© 2017, Krieg et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 3,683
    Page views
  • 718
    Downloads
  • 75
    Citations

Article citation count generated by polling the highest count across the following sources: Scopus, Crossref, PubMed Central.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Michael Krieg
  2. Jan Stühmer
  3. Juan G Cueva
  4. Richard Fetter
  5. Kerri A Spliker
  6. Daniel Cremers
  7. Kang Shen
  8. Alexander R Dunn
  9. Miriam B Goodman
(2017)
Genetic defects in β-spectrin and tau sensitize C. elegans axons to movement-induced damage via torque-tension coupling
eLife 6:e20172.
https://doi.org/10.7554/eLife.20172

Share this article

https://doi.org/10.7554/eLife.20172

Further reading

    1. Cell Biology
    2. Plant Biology
    Maciek Adamowski, Ivana Matijević, Jiří Friml
    Research Article

    The GNOM (GN) Guanine nucleotide Exchange Factor for ARF small GTPases (ARF-GEF) is among the best studied trafficking regulators in plants, playing crucial and unique developmental roles in patterning and polarity. The current models place GN at the Golgi apparatus (GA), where it mediates secretion/recycling, and at the plasma membrane (PM) presumably contributing to clathrin-mediated endocytosis (CME). The mechanistic basis of the developmental function of GN, distinct from the other ARF-GEFs including its closest homologue GNOM-LIKE1 (GNL1), remains elusive. Insights from this study largely extend the current notions of GN function. We show that GN, but not GNL1, localizes to the cell periphery at long-lived structures distinct from clathrin-coated pits, while CME and secretion proceed normally in gn knockouts. The functional GN mutant variant GNfewerroots, absent from the GA, suggests that the cell periphery is the major site of GN action responsible for its developmental function. Following inhibition by Brefeldin A, GN, but not GNL1, relocates to the PM likely on exocytic vesicles, suggesting selective molecular associations en route to the cell periphery. A study of GN-GNL1 chimeric ARF-GEFs indicates that all GN domains contribute to the specific GN function in a partially redundant manner. Together, this study offers significant steps toward the elucidation of the mechanism underlying unique cellular and development functions of GNOM.

    1. Biochemistry and Chemical Biology
    2. Cell Biology
    Chenjie Xia, Huihui Xu ... Hongting Jin
    Research Article

    Glucocorticoid-induced osteonecrosis of the femoral head (GONFH) is a common refractory joint disease characterized by bone damage and the collapse of femoral head structure. However, the exact pathological mechanisms of GONFH remain unknown. Here, we observed abnormal osteogenesis and adipogenesis associated with decreased β-catenin in the necrotic femoral head of GONFH patients. In vivo and in vitro studies further revealed that glucocorticoid exposure disrupted osteogenic/adipogenic differentiation of bone marrow mesenchymal cells (BMSCs) by inhibiting β-catenin signaling in glucocorticoid-induced GONFH rats. Col2+ lineage largely contributes to BMSCs and was found an osteogenic commitment in the femoral head through 9 mo of lineage trace. Specific deletion of β-catenin gene (Ctnnb1) in Col2+ cells shifted their commitment from osteoblasts to adipocytes, leading to a full spectrum of disease phenotype of GONFH in adult mice. Overall, we uncover that β-catenin inhibition disrupting the homeostasis of osteogenic/adipogenic differentiation contributes to the development of GONFH and identify an ideal genetic-modified mouse model of GONFH.